Delivery Order SPE2DB20D7059-SPE2DB25FQKM6
Award Date
6/25/25
Potential Completion Date
6/26/25
Potential Value
$9.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the supply of MENQUADFI VIAL 0.5ML medical products to the Defense Logistics Agency (DLA), a defense agency. The $1,371.27 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of May 1, 2023 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of MENQUADFI VIAL 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense (DoD). The prime contractor is Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the federal government. The contract, valued at $7,024.80, is a Firm Fixed Price Delivery Order with a completion date of July 15, 2024. Amerisourcebergen holds a larger Indefinite...
This federal contract award is for the delivery of MENQUADFI VIAL 0.5ML medical supplies, valued at $63,547.65, to the Defense Logistics Agency (DLA). The award was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on March 1, 2024, with a completion date of March 4, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999...
This federal contract award is for the delivery of MENQUADFI VIAL 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), valued at up to $999,999,999 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of medical commodities,...
This federal contract award is a Delivery Order with a Firm Fixed Price contract type valued at $85,619.69, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides for the delivery of MENQUADFI VIAL 0.5ML, a medical product, with a performance period ending on June 12, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award is for the delivery of MENQUADFI VIAL 0.5ML medical supplies to the Defense Logistics Agency (DLA) by prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract has a ceiling value of $1,404.96 and a completion date of May 7, 2024. It is a Firm Fixed Price Delivery Order contract with no set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) valued up to...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,185.96 firm fixed-price contract is for the delivery of MENQUADFI VIAL 0.5ML medical supplies. The award has an ultimate completion date of January 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,560.74 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The...
This federal contract award is for the delivery of MENQUADFI VIAL 0.5ML medical supplies, with a ceiling value of $14,515.40. The contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price pricing type and an ultimate completion date of March 19, 2025. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that...
This federal contract award is a delivery order valued at $1,452.88 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MENQUADFI VIAL 0.5ML, with a completion date of June 18, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) worth $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a...